NEW YORK (GenomeWeb News) – GenMark Diagnostics said after the close of the market on Wednesday that revenues for its second quarter increased 44 percent year over year with strong growth in reagent and instrument revenues.

For the three months ended June 30, total revenues rose to $5.2 million from $3.6 million and beat the average Wall Street estimate of $5.1 million. The increase, GenMark said, "reflects an increase in the number of systems placed at customer sites, growth in test menus, and an increase in the number of tests sold."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.